Full-Time
Principal Mechanical Design Engineer - Technical Leader
Technical Leadership
Posted on 3/16/2025
Nemera
1,001-5,000 employees
Designs, develops, manufactures drug delivery devices
No salary listed
Chicago, IL, USA
In Person
 Mechanical Engineering (1) |
|---|
- Bachelor’s or Master’s degree in Mechanical Engineering
- 7+ years of product development experience
- Strong knowledge of regulatory requirements (FDA, ISO, etc.)
- Proficiency in CAD software, Solid Works and other relevant engineering tools
- Experience with managing all technical aspects of device development
- Experience with high volume production, injection molding and automation
- Coordinate & lead technical design team within one or more programs while working in a multi-disciplinary, multi-site environment
- Understand priorities to develop and communicate action plans internally and externally
- Assist in defining the planning and resources required to achieve the success of the technical design activities of programs
- Identify potential problems early and suggest options based upon cost, time and requirements
- Design, build and test prototypes to characterize performance
- Solve complex technical problems within the bounds of timing and cost constraints
- Work with Nemera’s injection molding tooling experts to successfully implement DFM and DFA into detailed designs ready for high-volume manufacturing
- Guide and mentor junior engineers
- Excellent communication and interpersonal skills, with a demonstrated ability to lead technical teams.
- Ability to network across the organization to support activities across multiple sites
- Experience working in a consulting environment
- Familiar with the basics of electronics and software
Nemera designs, develops, and manufactures drug delivery devices for pharmaceutical and biotech companies, spanning ophthalmic, nasal, buccal, parenteral, dermal, and inhalation routes. The devices are used to administer medicines and are developed and manufactured in collaboration with customers, often through co-development and customized production in a B2B model. It stands out by offering an end-to-end range of delivery solutions across multiple administration routes, supported by global manufacturing facilities and a wide distribution network. Its goal is to enable safer, more convenient self-administered therapies by providing scalable devices and related design and manufacturing services to partners.
Company Size
1,001-5,000
Company Stage
Acquired
Total Funding
$1.2B
Headquarters
La Verpillière, France
Founded
2014
Simplify's Take
What believers are saying
- Rising demand for diabetes and obesity injection pens drives La Verpillière expansion, starting production 2027.
- New Szczecin hall strengthens leadership in GLP-1 drug market for obesity therapies.
- Milfra acquisition in June 2021 expands footprint in Brazil's gynecology and urology markets.
What critics are saying
- SteadyMed's Releev One captures Symbioze market share in GLP-1 delivery within 12-18 months.
- Ypsomed's dose accuracy wins Novo Nordisk contracts, undercutting La Verpillière capacity in 6-12 months.
- SHL Medical's DAI platform displaces Nemera's devices in Eli Lilly obesity pens within 12-24 months.
What makes Nemera unique
- Nemera specializes in drug delivery devices across ophthalmic, nasal, buccal, parenteral, dermal, and inhalation routes.
- Launched Symbioze wearable injector in October 2021 for self-administration needs.
- Introduced UniSpray unidose nasal system for emergency systemic drug delivery.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Company News
Nemera, a global leader in the design, development, and manufacturing of drug delivery device solutions, has inaugurated a new production hall at its state-of-the-art facility in Szczecin, Poland.
That's the new space Nemera has acquired to set up the next state-of-the-art manufacturing facility.
In May of 2014, Rexam sold the plastics business and the Berlin Plant was acquired by Nemera, naming the prescription products business as Centor Inc.
French medical device manufacturer Nemera is expanding its industrial footprint in suburban Chicago.
Nemera France SAS is thrilled to announce the publication of its first integrated ESG report.